Dow, S&P 500, Nasdaq futures rise as Tesla, Meta, Microsoft diverge after earnings
January 29, 2026
Breaking News
Image source: Unsplash
US stock futures stepped higher on Thursday as investors digested a fresh batch of megacap earnings alongside the Federal Reserve’s latest policy decision.
Nasdaq 100 futures rose 0.2%, as did those on the S&P 500. Contracts on the Dow Jones Industrial Average, which includes fewer technology names, nudged 0.1% higher after the major indexes closed little changed on Wednesday.
Meta shares jumped in premarket trading after its quarterly revenue outlook beat Wall Street estimates, as it laid out plans to spend up to $135 billion on its artificial intelligence data center build-out this year.
Microsoft stock slid as investors reacted to slower cloud growth during its fiscal second quarter and higher-than-anticipated capital spending and finance lease costs. Yahoo Finance reports.
EdgeUp
🤖 Meta stock climbs on Q4 earnings beat, plans to spend as much as $135 billion on AI build-out in 2026
Meta stock climbs on Q4 earnings beat, plans to spend as much as $135 billion on AI build-out in 2026
Meta stock climbed early on Thursday after its fourth quarter earnings topped analysts’ expectations on both the top and bottom lines.
The company also shared its 2026 capital expenditure outlook, saying it expects to spend between $115 billion and $135 billion in 2026, up from $72.22 billion spent in 2025.
Meta shares jumped as much as 10% shortly after the announcement on Wednesday and were up nearly 8% in premarket trading on Thursday. Yahoo Finance reports.
🤖 From Meta to Samsung, tech firms unleash AI spending spree
The world’s largest tech firms show no signs of easing up on AI spending, a record wave that’s propelling hardware providers like Samsung Electronics Co. and SK Hynix Inc.
That’s even as doubts persist about the staying power of artificial intelligence demand to justify all that capital.
Meta Platforms Inc. alone revealed ambitions to spend as much as $135 billion this year — one of the biggest planned outlays of the business sphere.
Its suppliers have responded in kind. On Thursday, SK Hynix said it plans a “considerable increase” in capital spending, and Samsung said it’s ratcheting up investment in its memory production capacity. Yahoo Finance reports.
🖥️ Microsoft stock drops in premarket after record AI spend puts Azure payoff in focus
Microsoft shares slipped 5.7% to roughly $454 in premarket Thursday, rattled by concerns over the rising expenses tied to its AI strategy following the latest quarterly report.
The stock had closed Wednesday slightly higher, up 0.2% at $481.63.
This shift is significant because investors have long seen Microsoft as a key indicator of enterprise AI demand.
More are now setting stricter conditions: spending is acceptable, but only if growth stays on track. TechStock² reports.
🖥️ IBM stock price jumps before the bell after earnings beat — what traders are watching next
Shares of International Business Machines (IBM) surged in premarket action Thursday, climbing 7.86% to $317.27 by 5:00 a.m. EST. The stock had closed Wednesday at $294.16.
Investors are sorting through a packed earnings slate and a calmer rates environment after the Federal Reserve held steady on policy.
Tech stocks have shown mixed responses, with strong earnings quickly attracting buying pressure in late and early trading sessions.
IBM’s latest results land amid a tough debate over whether AI investments are driving steady revenue or just hype. TechStock² reports.
🧬 Why did SER stock surge over 70% in pre-market today?
Shares of Serina Therapeutics surged more than 70% in pre-market trading on Thursday after the company announced that the US Food and Drug Administration cleared its investigational new drug application for SER-252, a therapy aimed at treating patients with Parkinson’s disease.
SER-252 is an experimental apomorphine-based therapy designed to provide continuous dopaminergic stimulation, an approach shown to ease levodopa-related motor complications such as dyskinesia in people with Parkinson’s disease.
The stock had already jumped nearly 35% in after-hours trading on Wednesday. TradingView reports.
Top 5 Movers in Early Pre-Market
(All pricing and percent gains are based on Early Pre-Market from 4:00 AM to 7:00 AM Eastern Time)
Stock Analysis reports.
1) SER: Serina Therapeutics, Inc.
Total gain: +77.94%
2) VTIX: Virtuix Holdings Inc.
Total gain: +37.77%
3) VENU: Venu Holding Corporation
Total gain: +20.15%
4) ROLR: High Roller Technologies, Inc.
Total gain: +15.38%
5) NAMM: Namib Minerals
Total gain: +14.22%
Yesterday’s Biggest Movers
The closing price of the top three market percent gainers trading near or above $3 on January 28.
Stock Analysis reports.
*All pricing and percent gains are based on regular market trading hours from 9:30am to 4:00pm Eastern Time
1) TIRX: Tian Ruixiang Holdings Ltd.
Total gain: +311.21%
The company announced that it has entered into a strategic Memorandum of Understanding ("MOU") with its strategic investor, SwiftStart Inc. Pursuant to the MOU, SwiftStart Inc. has expressed its intention to pursue an initial equity investment in TIRX at a proposed purchase price of US$1.50 per share, with a proposed total investment amount of US$80 million. PR Newswire reports.
2) NAMM: Namib Minerals
Total gain: +35.88%
The stock appeared to be moving on no notable news.
3) PCLA: PicoCELA Inc.
Total gain: +32.79%
The stock appeared to be moving on no notable news.
Today’s Notable Earnings
*Estimate and Actual numbers represent Earnings Per Share in US Dollars
TAL: TAL Education
Q3 2026
Before Market Open
Estimate: 0.060
Actual: 0.250
LYG: Lloyds Banking Group
Q4 2025
Before Market Open
Estimate: 0.100
Actual: 0.116
DB: Deutsche Bank
Q4 2025
Before Market Open
Estimate: 0.720
Actual: 0.884
Today’s Economic Dates
Time (ET) / Report / Period
9:00 AM - Case Shiller 20-city home price index - Nov.
10:00 AM - Consumer confidence - Jan.
Parting Thoughts
“I never assume the market is wrong. I assume my view can be wrong.”
– Takashi Kotegawa
Sourced in: Interview with BNF – Financial Times.
Disclaimer
TradeZero America, Inc., a United States broker dealer, registered with the Securities and Exchange Commission (SEC) and member of the Financial Industry Regulatory Authority (FINRA) and the Securities Investor Protection Corporation (SIPC); TradeZero, Inc., a Bahamian broker dealer, registered with the Securities Commission of the Bahamas ; TradeZero Canada Securities ULC, a Canadian broker dealer, member firm of Canadian Investment Regulatory Organization (CIRO) and member of the Canadian Investor Protection Fund (CIPF); and TradeZero Europe B.V., a Dutch broker dealer, authorized and regulated by the Dutch Authority for the Financial Markets (AFM) (collectively, the “TradeZero Broker Dealers”).
TradeZero Broker Dealers offer self-directed electronic securities trading to their customers. TradeZero Broker Dealers do not provide financial or trading advice and do not make investment recommendations to their customers. This communication does not constitute an offer to sell or a solicitation to buy any security or instrument which it may reference. There is a risk of loss in online trading of securities including equities and options. Trading on margin is for experienced investors whereby the loss can be greater than your initial investment. Likewise, short selling as a securities trading strategy is extremely risky and can lead to potentially unlimited losses. Options trading is not suitable for all investors as it can involve risk that may expose investors to significant losses. Please read the Characteristics and Risks of Standardized Options, also known as the Options Disclosure Document (ODD) at OCC.
If you have any specific questions about TradeZero's brokerage services, please reach out to the TradeZero Broker Dealer servicing your jurisdiction.